Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,030 | -1,053 | -995 | -3,419 | -400 |
| Depreciation Amortization | 2,745 | 2,849 | 2,879 | 3,260 | 3,203 |
| Accounts receivable | -1,675 | -66 | 21 | -204 | -131 |
| Other Working Capital | -5,542 | -504 | -47 | 200 | -721 |
| Other Operating Activity | 3,117 | 515 | 298 | 737 | 880 |
| Operating Cash Flow | $-6,385 | $1,741 | $2,156 | $574 | $2,831 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 134 | N/A |
| PPE Investments | -1,751 | -2,697 | -2,667 | -2,674 | -2,168 |
| Net Acquisitions | N/A | N/A | -160 | -200 | N/A |
| Purchase Sale Intangibles | -150 | N/A | N/A | N/A | -35 |
| Other Investing Activity | -150 | 0 | 50 | -50 | -35 |
| Investing Cash Flow | $-1,901 | $-2,697 | $-2,777 | $-2,790 | $-2,203 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,049 | 1,607 | 0 | 123 | N/A |
| Debt Repayment | -2,348 | -184 | -357 | -459 | -425 |
| Common Stock Issued | 6,413 | 2,343 | 2,310 | 36 | 61 |
| Other Financing Activity | -33 | -16 | -1 | 0 | 0 |
| Financing Cash Flow | $10,081 | $3,750 | $1,952 | $-300 | $-364 |
| Exchange Rate Effect | -65 | -60 | 16 | -16 | 5 |
| Beginning Cash Position | 5,455 | 2,721 | 1,374 | 3,906 | 3,637 |
| End Cash Position | 7,185 | 5,455 | 2,721 | 1,374 | 3,906 |
| Net Cash Flow | $1,730 | $2,734 | $1,347 | $-2,532 | $264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,385 | 1,741 | 2,156 | 574 | 2,831 |
| Capital Expenditure | -1,751 | -2,697 | -2,667 | -2,674 | -2,168 |
| Free Cash Flow | -8,136 | -956 | -511 | -2,100 | 663 |